SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells
Abstract Background Hyperinflammation, hypercoagulation and endothelial injury are major findings in acute and post-COVID-19. The SARS-CoV-2 S protein has been detected as an isolated element in human tissues reservoirs and is the main product of mRNA COVID-19 vaccines. We investigated whether the S...
Main Authors: | Alicia Villacampa, Enrique Alfaro, Cristina Morales, Elena Díaz-García, Cristina López-Fernández, José Luis Bartha, Francisco López-Sánchez, Óscar Lorenzo, Salvador Moncada, Carlos F. Sánchez-Ferrer, Francisco García-Río, Carolina Cubillos-Zapata, Concepción Peiró |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12964-023-01397-6 |
Similar Items
-
Correction: SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells
by: Alicia Villacampa, et al.
Published: (2024-01-01) -
Apigenin inhibits NLRP3 inflammasome activation in monocytes and macrophages independently of CD38
by: Knut Husø Lauritzen, et al.
Published: (2025-01-01) -
The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
by: Yang Gyun Kim, et al.
Published: (2019-11-01) -
NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns
by: Bo Wei, et al.
Published: (2024-07-01) -
Fantastic voyage: The journey of NLRP3 inflammasome activation
by: Xiangyong Que, et al.
Published: (2024-03-01)